Yi Zhan-Miao, Song Zai-Wei, Li Xin-Ya, Hu Yang, Cheng Yin-Chu, Wang Guan-Ru, Zhao Rong-Sheng
Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
Ann Transl Med. 2021 Sep;9(18):1479. doi: 10.21037/atm-21-4157.
The International Pharmaceutical Federation (FIP) has established an interim guidance of coronavirus disease 2019 (COVID-19) for pharmacists worldwide. The aim of this study was to identify the implementation of FIP guidance in China and provide applicable strategies for further actions.
A nationwide cross-sectional survey on Chinese pharmacists was distributed electronically through groups of WeChat between 9 December 2020 and 18 December 2020. The 29-item questionnaire for the survey was designed based on the FIP guidance and knowledge, attitudes, and practices (KAP) framework.
A total of 237 responses from 237 pharmacists (69.20% females) were received. Most pharmacists (81.86%) participated in work related to COVID-19. Respondents referred to other guidelines or consensus more than they did to FIP guidance. Most participants were qualified for the knowledge-based questions regarding COVID-19 (67.51%), had positive attitudes towards pharmacists' roles and actions (61.18%), and were qualified in the practices of prevention measures, infection risk monitoring, and pharmacists' advice (50.63%). Several factors were revealed as having impact on pharmacists' KAP, such as the relevance of participating in work related to COVID-19, work entailments, and information source.
The FIP guidance has a certain degree of dissemination and implementation in China, which can be improved through effective actions directed towards impact factors.
国际药学联合会（FIP）已为全球药剂师制定了2019冠状病毒病（COVID-19）临时指南。本研究旨在确定FIP指南在中国的实施情况，并为进一步行动提供适用策略。
2020年12月9日至2020年12月18日期间，通过微信群组以电子方式对中国药剂师进行了全国性横断面调查。该调查的29项问卷是基于FIP指南以及知识、态度和实践（KAP）框架设计的。
共收到来自237名药剂师的237份回复（女性占69.20%）。大多数药剂师（81.86%）参与了与COVID-19相关的工作。受访者参考其他指南或共识的频率高于FIP指南。大多数参与者在关于COVID-19的知识问题上合格（67.51%），对药剂师的角色和行动持积极态度（61.18%），并且在预防措施、感染风险监测和药剂师建议的实践方面合格（50.63%）。研究揭示了几个对药剂师的知识、态度和实践有影响的因素，如参与COVID-19相关工作的相关性、工作内容和信息来源。
FIP指南在中国有一定程度的传播和实施，可通过针对影响因素采取有效行动加以改进。
